Chapter 1. Market Scope and Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Biochips Market, by Product
1.4.2 Europe Biochips Market, by Application
1.4.3 Europe Biochips Market, by End User
1.4.4 Europe Biochips Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.2 Executive Summary
2.1.3 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Europe Biochips Market by Product
3.1 Europe DNA Chip Market by Country
3.2 Europe Protein Chip Market by Country
3.3 Europe Lab-on-Chip Market by Country
3.4 Europe Other Products Market by Country
Chapter 4. Europe Biochips Market by Application
4.1 Europe Drug Discovery and Development Market by Country
4.2 Europe Disease Diagnostics Market by Country
4.3 Europe Genomics Market by Country
4.4 Europe Proteomics Market by Country
4.5 Europe Agriculture Market by Country
4.6 Europe Other Applications Market by Country
Chapter 5. Europe Biochips Market by End User
5.1 Europe Biotechnology and Pharmaceutical Sector Market by Country
5.2 Europe Hospitals and Diagnostics Centers Market by Country
5.3 Europe Academic and Research Institutes Market by Country
5.4 Europe Other End Users Market by Country
Chapter 6. Europe Biochips Market by Country
6.1 Germany Biochips Market
6.1.1 Germany Biochips Market by Product
6.1.2 Germany Biochips Market by Application
6.1.3 Germany Biochips Market by End User
6.2 UK Biochips Market
6.2.1 UK Biochips Market by Product
6.2.2 UK Biochips Market by Application
6.2.3 UK Biochips Market by End User
6.3 France Biochips Market
6.3.1 France Biochips Market by Product
6.3.2 France Biochips Market by Application
6.3.3 France Biochips Market by End User
6.4 Russia Biochips Market
6.4.1 Russia Biochips Market by Product
6.4.2 Russia Biochips Market by Application
6.4.3 Russia Biochips Market by End User
6.5 Spain Biochips Market
6.5.1 Spain Biochips Market by Product
6.5.2 Spain Biochips Market by Application
6.5.3 Spain Biochips Market by End User
6.6 Italy Biochips Market
6.6.1 Italy Biochips Market by Product
6.6.2 Italy Biochips Market by Application
6.6.3 Italy Biochips Market by End User
6.7 Rest of Europe Biochips Market
6.7.1 Rest of Europe Biochips Market by Product
6.7.2 Rest of Europe Biochips Market by Application
6.7.3 Rest of Europe Biochips Market by End User
Chapter 7. Company Profiles
7.1 Fluidigm Corporation
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Regional Analysis
7.1.4 Research and Development Expense
7.2 Horiba Ltd.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research and Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and mergers:
7.3 PerkinElmer, Inc.
7.3.1 Company Overview
7.3.1 Financial Analysis
7.3.2 Segmental and Regional Analysis
7.3.3 Research and Development Expense
7.3.4 Recent strategies and developments:
7.3.4.1 Acquisition and mergers:
7.3.4.2 Product launches:
7.4 OriGene Technologies, Inc.
7.4.1 Company Overview
7.5 Dynamic Biosensors GmbH
7.5.1 Company Overview
7.6 Illumina, Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research and Development Expense
7.7 Qiagen N.V.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Regional Analysis
7.7.4 Research and Development Expense
7.8 Bio-Rad laboratories, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research and Development Expenses
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and mergers:
7.9 Randox Laboratories Limited
7.9.1 Company Overview
7.9.2 Recent strategies and developments:
7.9.2.1 Collaborations, partnerships and agreements:
7.9.2.2 Product launches:
7.1 Thermo Fischer Scientific, Inc.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research and Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Collaborations, partnerships and agreements:
Unique Offerings 